Heartcore Enterprises, Inc. - Form 8-K Summary
Business Context and Reporting Period
Heartcore Enterprises, Inc. (HTCR), an emerging growth company incorporated in Delaware, filed this Current Report on Form 8-K on June 22, 2026. The filing details a strategic divestiture completed on the same date, marking the exit from a majority-owned subsidiary.
Key Financial Metrics and Transaction Details
The Company sold its 51% majority ownership interest in Sigmaways, Inc., along with associated debt obligations. Key financial terms include:
- Assets Sold: 229,500 shares of Sigmaways capital stock and $2.19 million in outstanding promissory notes owed by Sigmaways to Heartcore.
- Total Consideration: Up to $650,000, reflecting the disputed nature of the underlying assets.
- Payment Structure:
- $1,000 cash payment at closing.
- Up to $649,000 earn-out payable within 10 days of the 12-month post-closing period.
- Earn-out calculation: 10% of Sigmaways' Gross Revenue exceeding $5,500,000.
- Additional Consideration: Transfer of a $350,000 Simple Agreement for Future Equity (SAFE) Note issued by Heart-Tech Health, Inc. to Semaphore Technologies, Inc. as part of a mutual release of claims.
The filing does not provide specific revenue, profit, cash flow, or margin data for Heartcore Enterprises, Inc. for the reporting period, as this is a transaction-specific report rather than a periodic financial statement.
Material Changes
Following the closing on June 22, 2026, Heartcore Enterprises has no further operational involvement or obligations regarding Sigmaways, Inc. The transaction removes the $2.19 million in intercompany debt from the Company's balance sheet, subject to the earn-out conditions.
Outlook, Risks, and Contingencies
Management characterized the transaction as a strategic divestiture. The low initial cash consideration ($1,000) and the contingent earn-out structure highlight the uncertainty regarding the collectability and value of the Sigmaways assets. The agreement includes a liability cap equal to the amount actually paid to the Company, except in cases of fraud. A press release regarding this divestiture was issued on June 25, 2026.
Investor Verification Checklist
- Verify the current status and gross revenue of Sigmaways, Inc. to assess the likelihood of the $649,000 earn-out payment.
- Review the full text of the Stock and Debt Purchase Agreement (Exhibit 10.1) for specific definitions of "Gross Revenue" and dispute resolution mechanisms.
- Confirm the impact of removing the $2.19 million intercompany debt on the Company's consolidated balance sheet in the next quarterly report.
- Assess the implications of the mutual release of claims involving the Heart-Tech Health, Inc. SAFE Note.